Dashboard
1
The company has declared Positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 8,230.45 MM
- NET SALES(HY) At CNY 11,126.28 MM has Grown at 30.93%
- ROCE(HY) Highest at 24.43%
2
With ROE of 24.27%, it has a very attractive valuation with a 2.34 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
CNY 71,446 Million (Large Cap)
10.00
NA
3.03%
0.02
24.27%
2.34
Revenue and Profits:
Net Sales:
5,585 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,734 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.69%
0%
13.69%
6 Months
14.74%
0%
14.74%
1 Year
31.79%
0%
31.79%
2 Years
59.16%
0%
59.16%
3 Years
10.24%
0%
10.24%
4 Years
-5.26%
0%
-5.26%
5 Years
29.69%
0%
29.69%
Zhejiang NHU Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
20.37%
EBIT Growth (5y)
17.51%
EBIT to Interest (avg)
16.35
Debt to EBITDA (avg)
0.62
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.49
Tax Ratio
13.87%
Dividend Payout Ratio
26.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.26%
ROE (avg)
16.94%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
2.34
EV to EBIT
8.73
EV to EBITDA
6.83
EV to Capital Employed
2.32
EV to Sales
3.18
PEG Ratio
0.08
Dividend Yield
3.03%
ROCE (Latest)
26.61%
ROE (Latest)
24.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
5,585.40
5,389.10
3.64%
Operating Profit (PBDIT) excl Other Income
2,570.20
2,612.20
-1.61%
Interest
54.30
58.40
-7.02%
Exceptional Items
-90.70
-16.10
-463.35%
Consolidate Net Profit
1,733.80
1,887.70
-8.15%
Operating Profit Margin (Excl OI)
356.20%
377.00%
-2.08%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 3.64% vs -6.07% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -8.15% vs -0.03% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
21,358.80
14,949.80
42.87%
Operating Profit (PBDIT) excl Other Income
9,149.30
4,717.90
93.93%
Interest
290.80
326.70
-10.99%
Exceptional Items
-45.10
29.10
-254.98%
Consolidate Net Profit
5,896.90
2,725.40
116.37%
Operating Profit Margin (Excl OI)
323.80%
201.10%
12.27%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 42.87% vs -5.42% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 116.37% vs -25.09% in Dec 2023
About Zhejiang NHU Co. Ltd. 
Zhejiang NHU Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






